v3.26.1
Stockholders' Equity
 6 Months Ended
Apr. 03, 2026
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY
10.    STOCKHOLDERS’ EQUITY

Stock Repurchase and Retirement
On February 4, 2025, the Board of Directors approved a stock repurchase program, pursuant to which the Company is authorized to repurchase up to $2.0 billion of its common stock from time to time through February 3, 2027, on the open market or in privately negotiated transactions, in compliance with applicable securities laws and other legal requirements. The timing and amount of any shares of the Company’s common stock that are repurchased under the stock repurchase program will be determined by the Company’s management based on its evaluation of market conditions and other factors. The stock repurchase program may be suspended or discontinued at any time. The Company currently expects to fund the stock repurchase program using the Company’s working capital.

During each of the three and six months ended April 3, 2026, the Company did not repurchase any shares of its common stock. As of April 3, 2026, approximately $1.2 billion remained available under the stock repurchase program.

During each of the three and six months ended March 28, 2025, the Company repurchased 7.4 million shares of its common stock for $504.3 million (including commissions and excise tax, as applicable), all of which shares were repurchased pursuant to the stock repurchase program.

Dividends
On May 5, 2026, the Company announced that the Board of Directors had declared a cash dividend on the Company’s common stock of $0.71 per share. This dividend is payable on June 16, 2026, to the Company’s stockholders of record as of the close of business on May 26, 2026. Future dividends are subject to declaration by the Board of Directors.

Dividends charged to retained earnings were as follows (in millions, except per share data):
Fiscal Years Ended
October 2, 2026October 3, 2025
Per ShareTotal AmountPer ShareTotal Amount
First quarter$0.71 $106.4 $0.70 $112.5 
Second quarter0.71 106.8 0.70 110.6 
Total dividends$1.42 $213.2 $1.40 $223.1 

Share-based Compensation
The following table summarizes the share-based compensation expense by line item in the Consolidated Statements of Operations (in millions):
Three Months EndedSix Months Ended
April 3, 2026March 28, 2025April 3, 2026March 28, 2025
Cost of goods sold$5.6 $5.7 $23.1 $13.0 
Research and development36.6 27.6 66.4 53.2 
Selling, general, and administrative15.8 16.9 26.2 35.1 
Restructuring, impairment, and other charges— 12.5 — 12.5 
Total share-based compensation$58.0 $62.7 $115.7 $113.8